Tamoxifen associated uterine pathology in rodents: Relevance to women

Carcinogenesis

Volumn 17, Issue 8, 1996, Pages 1577-1582

  Carthew, Philip ^a   Edwards, Richard E ^a   Nolan, Barbara M ^a   Martin, Elizabeth A ^a   Smith, Lewis L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATROPHY; CONTROLLED STUDY; DRUG CARCINOGENICITY; ENDOMETRIUM; ENDOMETRIUM ATROPHY; ENDOMETRIUM HYPERPLASIA; FEMALE; MOUSE; MYOMETRIUM; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STEREOMETRY; UTERUS; UTERUS TUMOR; UTERUS WEIGHT;

EID: 0029741034     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.8.1577     Document Type: Article

References (26)

1. Riley, D., Baum, M., Macintyre, J. et al. (1992)The effect of adjuvant tamoxifen - The latest results from the Cancer Research Campaign adjuvant breast trial. Eur. J. Cancer, 28A, 904-907.
2. Powles, T.J. (1992) The case for clinical trials of tamoxifen for prevention of breast cancer. Lancet, 340, 1145-1147.
3. Stone, R. (1992) NIH fends off critics of tamoxifen study. Science, 258, 734.
4. Hirsimaki, P., Hirsimaki, Y., Nieminen, L. and Payne, B.J. (1993) Tamoxifen induces hepatocellular carcinoma in rat liver - a 1-year study with two antiestrogens. Arch. Toxicol., 67, 49-54.
5. Greaves, S., Goonetilleke, R., Nunn, G., Topham, J. and Orton, T. (1993) Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats. Cancer Res., 53, 3919-3924.
6. Williams, G.M., Iatropoulos, M.J., Djordjevic, M.V. and Kaltenberg, O.P. (1993) The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat. Carcinogenesis, 14, 315-317.
7. Hard, G.C., Iatropoulos, M.J., Jordon, K., Radi, L., Kalterberg, O.P., Imondi, A.R. and Williams, G.M. (1993) Major differences in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl: CD(BR) rats. Cancer Res., 53, 4534-4541.
8. Dahme, E. and Rattel, B. (1994) In contrast to tamoxifen, droloxifene does not induce liver tumors in rats. Oncologie, 17 S1, 6-16.
9. 32P-postlabelling in three rat strains exposed to dietary tamoxifen:the relationship between cell proliferation and liver tumour formation. Carcinogenesis, 16, 1299-1304.
10. Carthew, P., Martin, E.A., White, I.N.H., De Matteis, F., Edwards, R.E., Dorman, B.M., Heydon, R.T. and Smith, L.L. (1995) Tamoxifen induces short-term cumulative DNA damage and liver tumours: promotion by phenobarbital. Cancer Res., 55, 544-547.
11. Tucker, M.J., Adam, H.K. and Patterson, J.S. (1984) Tamoxifen. In Laurence, D.R., McLean, A.E.M. and Weatherall, M. (eds), Safety Testing of New Drugs. Chapter 6, Academic Press, London.
12. Martin, E.A., Carthew, P., White, I.N.H. and Smith, L.L. (1996) A lifetime feeding study of tamoxifen in three strains of mice. The Toxicologist, 30, 201.
13. Wakeling A.E., O'Connor K.M. and Newboult, E. (1983) Comparison of the biological effects of tamoxifen and a new antioestrogen (LY117018) on the immature rat uterus. J. Endocrinol., 99, 447-453.
14. Cohen, I., Rosen, D.J.D., Tepper, R., Cordoba, M., Shapira, Y., Altaras, M.M., Yigael, D. and Beyth, Y. (1993) Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen. J. Ultrasound Med., 12, 275-280.
15. Fornander, T., Hellstom, A.C. and Moberger, B. (1993) Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer. J Natl Cancer Inst., 85, 1850-1855.
16. Van Leeuwen, F.E., Benraad, T.J., Coebergh, J.W.W. et al. (1994) Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet, 343, 448-452.
17. Kedar, R.P., Bourne, T.H., Powles, T.J., Collins, W.P., Ashley, S.E., Cosgrove, D.O. and Campbell, S. (1994) Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet, 343, 1318-1321.
18. Silva, E.G., Tornos, C.S. and Follen-Mitchell, M. (1994) Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effect of tamoxifen. Int. J. Gynecol. Pathol., 13, 248-258.
19. Weibel, E.R. (1979) Practical Methods for Biological Morphometry, Stereological Methods, vol. 1. Academic Press, London.
20. Collan, Y., Aalto, M.L., Kosma, V.M., Naukkarinem, A., Romppanen, T. and Syrjanen, K. (1984) Stereology and Morphometry in Pathology. Proceedings of the Second Symposium on Morphometry in Morphological Diagnosis. Kuopio University Press, Kuopio.
21. Boorman, G.A., Lewis, S.L., Elwell, M.R., Montgomery, C.A. Jr and MacKenzie, W.F. (1990) Pathology of the Fischer Rat. Academic Press, New York.
22. Carmichael, P.L., Ugwumadu, A.H., Neven, P., Hewer, A.J., Poon, G.K. and Phillips, D.H. (1996) Tamoxifen does not induce DNA adducts in human endometrium. Proc. Am. Assoc. Cancer Res., 37, 113.
23. Turteltaub, K.W., Vogel, J.S., Frantz, C.E. and Fultz, F. (1993) Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: a new technique for tracing isotope-labelled DNA adduction. In Phillips, D.H., Castegaro, M. and Bartsch, H. (eds), Postlabelling methods for detection of DNA adducts. IARC, Lyon, pp. 293-301.
24. Jordan, C.V. and Robinson, S.P. (1987) Species-specific pharmacology of antiestrogens: role of metabolism. Fed. Proc., 46, 1870-1874.
25. IARC (1996) Monograph on evaluation of carcinogenic risks to humans. 66, in press.
26. IARC (1996) Monograph conclusion on tamoxifen. Lancet, 347, 605.